EP Biocomposites Board of Directors

Get the latest insights into the leadership at EP Biocomposites. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Rajkumar KamatManaging Director
Leena KamatNon Executive Director
Shreyas NadkarniNon Executive Director
Nitin Anant KunkolienkerNon Executive Independent Director
Dinesh ShenoyNon Executive Independent Director
Aanchal AgrawalCompany Secretary & Compliance Officer

EP Biocomposites Share price

EPBIO

101

0.00 (0.00%)
Last updated on 4 May, 2026 | 11:41 IST
Today's High

103.95

Today's Low

101.00

52 Week Low

75.50

52 Week High

149.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

EP Biocomposites FAQs

The board at EP Biocomposites consists of experienced professionals, including Rajkumar Kamat, Leena Kamat, and others, overseeing the company’s strategic and corporate governance.

Directors at EP Biocomposites are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Rajkumar Kamat is the current chairman at EP Biocomposites.

Executive directors at EP Biocomposites are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, EP Biocomposites adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At EP Biocomposites, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost